• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种不同抗肿瘤效应细胞群的体内启动:MHC I类分子表达的作用

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.

作者信息

Levitsky H I, Lazenby A, Hayashi R J, Pardoll D M

机构信息

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

出版信息

J Exp Med. 1994 Apr 1;179(4):1215-24. doi: 10.1084/jem.179.4.1215.

DOI:10.1084/jem.179.4.1215
PMID:7908321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2191440/
Abstract

Downregulation of major histocompatibility complex (MHC) class I expression is an important mechanism by which tumors evade classical T cell-dependent immune responses. Therefore, a system was designed to evaluate parameters for active immunization against MHC class I- tumors. Mice were capable of rejecting a MHC class I- tumor challenge after immunization with an irradiated granulocyte/macrophage colony-stimulating factor (GM-CSF) transduced MHC class I- tumor vaccine. This response was critically dependent on CD4+ T cells and natural killer (NK) cells, but minimally on CD8+ T cells. A strong protective response against MHC class I+ variants of the tumor could be elicited when mice were immunized with irradiated MHC class I+ GM-CSF-secreting tumor cells. This response required CD4+ and CD8+ T cells, and in addition, elimination of NK cells resulted in outgrowth of tumors that had lost expression of at least one MHC class I gene. Finally, class I MHC expression on the vaccinating cells inhibited the response generated against a MHC class I- tumor challenge. These results demonstrate that the host is capable of being immunized against a tumor that has lost MHC class I expression and reveal conditions under which distinct effector cells play a role in the systemic antitumor immune response.

摘要

主要组织相容性复合体(MHC)I类分子表达下调是肿瘤逃避经典的T细胞依赖性免疫反应的重要机制。因此,设计了一个系统来评估针对MHC I类缺陷肿瘤进行主动免疫的参数。在用经辐射的粒细胞/巨噬细胞集落刺激因子(GM-CSF)转导的MHC I类缺陷肿瘤疫苗免疫后,小鼠能够排斥MHC I类缺陷肿瘤攻击。这种反应严重依赖于CD4 + T细胞和自然杀伤(NK)细胞,但对CD8 + T细胞的依赖极小。当用经辐射的分泌GM-CSF的MHC I类阳性肿瘤细胞免疫小鼠时,可引发针对肿瘤的MHC I类阳性变体的强烈保护性反应。这种反应需要CD4 +和CD8 + T细胞,此外,消除NK细胞会导致至少一个MHC I类基因表达缺失的肿瘤生长。最后,接种细胞上的I类MHC表达抑制了针对MHC I类缺陷肿瘤攻击产生的反应。这些结果表明,宿主能够针对已失去MHC I类表达的肿瘤进行免疫,并揭示了不同效应细胞在全身抗肿瘤免疫反应中发挥作用的条件。

相似文献

1
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.两种不同抗肿瘤效应细胞群的体内启动:MHC I类分子表达的作用
J Exp Med. 1994 Apr 1;179(4):1215-24. doi: 10.1084/jem.179.4.1215.
2
Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF and interferon-gamma.使用分泌粒细胞-巨噬细胞集落刺激因子(GM-CSF)和γ干扰素的双转导肿瘤细胞对神经母细胞瘤进行有效免疫。
J Immunother Emphasis Tumor Immunol. 1996 Mar;19(2):113-24. doi: 10.1097/00002371-199603000-00004.
3
NK1.1+ cells are important for the development of protective immunity against MHC I-deficient, HPV16-associated tumours.NK1.1+ 细胞对于针对 MHC I 缺陷、HPV16 相关肿瘤的保护性免疫的发展很重要。
Oncol Rep. 2011 Jan;25(1):281-8.
4
A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor.一种非经典的MHC I类分子限制了CTL介导的同基因黑色素瘤肿瘤排斥反应。
J Immunol. 2004 Oct 1;173(7):4394-401. doi: 10.4049/jimmunol.173.7.4394.
5
Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.粒细胞-巨噬细胞集落刺激因子基因转导的肿瘤细胞与肿瘤来源的gp96联合可抑制小鼠肿瘤生长。
Hum Gene Ther. 2003 May 20;14(8):715-28. doi: 10.1089/104303403765255129.
6
Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine.通过在同种异体疫苗接种部位表达粒细胞巨噬细胞集落刺激因子增强肿瘤保护作用。
Hum Gene Ther. 1998 Apr 10;9(6):835-43. doi: 10.1089/hum.1998.9.6-835.
7
GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.粒细胞-巨噬细胞集落刺激因子(GM-CSF)和B7-1(CD80)共刺激信号协同作用,诱导同基因小鼠产生有效的抗肿瘤免疫。
Int J Cancer. 1997 Nov 14;73(4):556-61. doi: 10.1002/(sici)1097-0215(19971114)73:4<556::aid-ijc17>3.0.co;2-7.
8
Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection.白细胞介素-2局部分泌引发的小鼠黑色素瘤排斥反应:表明巨噬细胞在肿瘤排斥反应中发挥作用,而无需T细胞或自然杀伤细胞参与。
Int J Cancer. 1995 Apr 10;61(2):253-60. doi: 10.1002/ijc.2910610219.
9
The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.细胞因子基因共转导对使用表达肿瘤相关抗原的基因修饰树突状细胞进行癌症疫苗治疗的增强作用。
Int J Oncol. 2006 Apr;28(4):947-53.
10
Correction of defects responsible for impaired Qa-2 class Ib MHC expression on melanoma cells protects mice from tumor growth.纠正导致黑色素瘤细胞上Qa-2 Ib类主要组织相容性复合体表达受损的缺陷可保护小鼠免受肿瘤生长。
J Immunol. 2003 May 1;170(9):4515-23. doi: 10.4049/jimmunol.170.9.4515.

引用本文的文献

1
MHC class Ib-restricted CD8 T cells possess strong tumoricidal activities.MHC 类 Ib 限制性 CD8 T 细胞具有强大的杀瘤活性。
Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2304689120. doi: 10.1073/pnas.2304689120. Epub 2023 Oct 19.
2
Roles of CD4+ T cells as mediators of antitumor immunity.CD4+ T 细胞作为抗肿瘤免疫的介质的作用。
Front Immunol. 2022 Sep 9;13:972021. doi: 10.3389/fimmu.2022.972021. eCollection 2022.
3
Short-course neoadjuvant in situ vaccination for murine melanoma.短程新辅助原位疫苗接种治疗鼠黑色素瘤。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003586.
4
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma.口咽鳞状细胞癌的肿瘤微环境与免疫治疗
Front Oncol. 2020 Dec 21;10:545385. doi: 10.3389/fonc.2020.545385. eCollection 2020.
5
IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma.IDO1 抑制增强了针对胰腺腺癌的疫苗诱导免疫。
J Clin Invest. 2019 Apr 1;129(4):1742-1755. doi: 10.1172/JCI124077. Epub 2019 Mar 18.
6
A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell-Mediated Anticancer Activity.CD40 激动剂和 PD-1 拮抗剂抗体重新编程无免疫原性肿瘤的微环境,以允许 T 细胞介导的抗癌活性。
Cancer Immunol Res. 2019 Mar;7(3):428-442. doi: 10.1158/2326-6066.CIR-18-0061. Epub 2019 Jan 14.
7
Migratory dendritic cells acquire and present lymphatic endothelial cell-archived antigens during lymph node contraction.迁移性树突状细胞在淋巴结收缩过程中获取并呈递淋巴管内皮细胞储存的抗原。
Nat Commun. 2017 Dec 11;8(1):2034. doi: 10.1038/s41467-017-02247-z.
8
Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression.同种异体 DRibble 疫苗联合抗 OX40 共刺激治疗导致交叉反应性效应 T 细胞的产生和肿瘤消退。
Sci Rep. 2016 Nov 22;6:37558. doi: 10.1038/srep37558.
9
Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.癌症治疗性Toll样受体配体诱导的肿瘤细胞死亡的差异性免疫调节活性
Cancer Immunol Immunother. 2016 Jun;65(6):689-700. doi: 10.1007/s00262-016-1828-3. Epub 2016 Mar 31.
10
Brain Tumor Immunotherapy: What have We Learned so Far?脑肿瘤免疫疗法:我们目前了解到了什么?
Front Oncol. 2015 Jun 17;5:98. doi: 10.3389/fonc.2015.00098. eCollection 2015.

本文引用的文献

1
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.用经基因工程改造以分泌小鼠粒细胞巨噬细胞集落刺激因子的辐照肿瘤细胞进行疫苗接种,可刺激产生强大、特异且持久的抗肿瘤免疫力。
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43. doi: 10.1073/pnas.90.8.3539.
2
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes.体内细胞毒性T淋巴细胞的生成需要辅助活性。
J Exp Med. 1982 Mar 1;155(3):768-82. doi: 10.1084/jem.155.3.768.
3
Response of resting human peripheral blood natural killer cells to interleukin 2.静息人外周血自然杀伤细胞对白介素2的反应
J Exp Med. 1984 Oct 1;160(4):1147-69. doi: 10.1084/jem.160.4.1147.
4
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.用单克隆抗体GK1.5鉴定的小鼠T细胞表面分子L3T4的特性:L3T4与人Leu-3/T4分子的相似性
J Immunol. 1983 Nov;131(5):2445-51.
5
Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation.MHC DNA介导的细胞转化后对可移植AKR白血病细胞的排斥反应。
Nature. 1984;311(5988):750-2. doi: 10.1038/311750a0.
6
Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones.将可选择基因和未选择序列高效地通过DNA介导转移到分化和未分化的小鼠黑色素瘤克隆中。
Somat Cell Mol Genet. 1984 Mar;10(2):139-51. doi: 10.1007/BF01534903.
7
IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.与携带Lyt 2抗原的分子复合物上不同决定簇发生反应的IgG或IgM单克隆抗体,在无补体情况下可阻断T细胞介导的细胞溶解作用。
J Immunol. 1980 Dec;125(6):2665-72.
8
Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.5-溴脱氧尿苷处理的小鼠黑色素瘤细胞的致瘤性、免疫原性及病毒产生
Proc Natl Acad Sci U S A. 1972 Nov;69(11):3443-7. doi: 10.1073/pnas.69.11.3443.
9
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.对H-2缺陷型淋巴瘤变体的选择性排斥表明存在替代免疫防御策略。
Nature. 1986;319(6055):675-8. doi: 10.1038/319675a0.
10
Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection.H-2基因转染后通过H-2K抗原的从头表达消除肿瘤细胞的转移特性。
Nature. 1985;315(6017):301-5. doi: 10.1038/315301a0.